Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CELSR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CD207 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IL21R - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF143 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAPK14 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BUB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HSPB7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RABGAP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC101060363 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GGA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CNKSR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PYGO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAPK8IP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PVT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
RAG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CD58 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BBS9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
B4GALT6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDGFB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on